IL-1 and T helper immune responses

Frontiers in Immunology

Volumn 4, Issue JUL, 2013, Pages

  Santarlasci, Veronica ^a   Cosmi, Lorenzo ^a   Maggi, Laura ^a   Liotta, Francesco ^a   Annunziato, Francesco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

IL 1 and T cells; IL 1RI and T cells; Th1 non classic; Th17 cells; Th2 cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 4;

ALLERGIC ASTHMA; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SURVIVAL; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; TH2 CELL; TUMOR IMMUNITY;

EID: 84883694766     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00182     Document Type: Review

References (59)

1. 4+ T cells. Arthritis Res Ther (2009) 11:257. doi:10.1186/ar2843
2. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev (2000) 14:1693-711.
3. -9 neutralization: correlation with worm expulsion in murine nematode infections. Infect Immun (2003) 71:2430-8. doi:10.1128/IAI.71.5.2430-2438.2003
4. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol (2000) 22:649-56. doi:10.1165/ajrcmb.22.6.3927
5. 2 paradigm. Immunol Today (1997) 18:263-6. doi:10.1016/S0167-5699(97)80019-9
6. 17 cells. Blood (2010) 115:335-43. doi:10.1182/blood-2009-04-216085
7. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity (2008) 28:454-67. doi:10.1016/j.immuni.2008.03.004
8. -17 through IL-6 paracrine/autocrine loop. J Biol Chem (2003) 278:17036-43.
9. -17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NFkappaB signaling pathways. J Immunol (2004) 173:3482-91.
10. -17 cells in the circle of immunity and autoimmunity. Nat Immunol (2007) 8:345-50. doi:10.1038/ni0407-345
11. 2 paradigm in allergy. Immunotechnology (1998) 3:233-44. doi:10.1016/S1380-2933(97)10005-7
12. 17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med (2011) 9:122. doi:10.1186/1741-7015-9-122
13. Martin MU, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta (2002) 1592:265-80. doi:10.1016/S0167-4889(02)00320-8
14. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol (2001) 22:328-36. doi:10.1016/S1471-4906(01)01941-X
15. Riva F, Bonavita E, Barbati E, Muzio M, Mantovani A, Garlanda C. TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor family member with regulatory functions in inflammation and immunity. Front Immunol (2012) 3:322. doi:10.3389/fimmu.2012.00322
16. Yoshida T, Shiroshima T, Lee SJ, Yasumura M, Uemura T, Chen X, et al. Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule. J Neurosci (2012) 32:2588-600. doi:10.1523/JNEUROSCI.4637-11.2012
17. -33 families of cytokines. Immunol Rev (2008) 223:20-38. doi:10.1111/j.1600-065X.2008.00624.x
18. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 27:519-50. doi:10.1146/annurev.immunol.021908.132612
19. Herrmann F, Oster W, Meuer SC, Lindemann A, Mertelsmann RH. Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor. J Clin Invest (1988) 81:1415-8. doi:10.1172/JCI113471
20. Lichtman AH, Chin J, Schmidt JA, Abbas AK. Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A (1988) 85:9699-703. doi:10.1073/pnas.85.24.9699
21. Shirakawa F, Tanaka Y, Ota T, Suzuki H, Eto S, Yamashita U. Expression of interleukin 1 receptors on human peripheral T cells. J Immunol (1987) 138:4243-8.
22. 4+ T cells specific for Plasmodium chabaudi. Immunology (1994) 81:216-21.
23. 2 cell activation and the development of airway hypersensitivity response. Int Immunol (2003) 15:483-90. doi:10.1093/intimm/dxg054
24. 2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol (2003) 33:991-1000. doi:10.1002/eji.200323801
25. 2-mediated immunity. Eur J Immunol (2004) 34:3674-81. doi:10.1002/eji.200425452
26. -1 type 1 receptor-deficient mice. Eur J Immunol (1998) 28:2066-74. doi:10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X
27. 2) human T-cell clones. Res Immunol (1994) 145:93-100. doi:10.1016/S0923-2494(94)80019-7
28. -4. J Allergy Clin Immunol (2010) 125:222-30. doi:10.1016/j.jaci.2009.10.012
29. -17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med (2010) 207:2479-91. doi:10.1084/jem.20101376
30. 2 cells. Adv Exp Med Biol (2001) 495:25-9. doi:10.1007/978-1-4615-0685-0_4
31. 2 cells in vivo. J Immunol (1999) 162:1278-86.
32. -1RI) as potential new therapeutic target for bronchial asthma. Mediators Inflamm (2010a) 2010:567351. doi:10.1155/2010/567351
33. -17-producing T cells. Immunity (2006) 24:179-89. doi:10.1016/j.immuni.2006.01.001
34. -17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med (2006) 203:1685-91. doi:10.1084/jem.20060285
35. -17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J Leukoc Biol (2010) 88:227-32. doi:10.1189/jlb.0809550
36. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med (2000) 191:313-20. doi:10.1084/jem.191.2.313
37. 17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum (2008) 58:3461-70. doi:10.1002/art.23957
38. 17 responses and arthritis severity in mice with a deficiency of myeloid cellspecific interleukin-1 receptor antagonist. Arthritis Rheum (2010) 62:452-62. doi:10.1002/art.27235
39. 17 cells. J Exp Med (2012) 209:1595-609. doi:10.1084/jem.20111453
40. 17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med (2007) 204:2803-12. doi:10.1084/jem.20071397
41. 17 cell differentiation by interleukin-1 signaling. Immunity (2009) 30:576-87. doi:10.1016/j.immuni.2009.02.007
42. 17 cells. J Exp Med (2007) 204:1849-61. doi:10.1084/jem.20070663
43. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol (2007) 8:942-9. doi:10.1038/ni1496
44. 4+ T cell precursor. J Exp Med (2008) 205:1903-16. doi:10.1084/jem.20080397
45. 17 cells by inhibiting Th1 cells. Eur J Immunol (2009) 39:207-15. doi:10.1002/eji.200838748
46. 17 cells via differential expression of IL-1 receptor. Blood (2010b) 115:530-40. doi:10.1182/blood-2009-08-236521
47. 17 from FOXP3+ naive regulatory T cells. J Immunol (2011) 187:5196-202. doi:10.4049/jimmunol.1101742
48. Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, et al. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol (2004) 138:323-9. doi:10.1111/j.1365-2249.2004.02599.x
49. Lasiglie D, Traggiai E, Federici S, Alessio M, Buoncompagni A, Accogli A, et al. Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients. PLoS ONE (2011) 6:e20014. doi:10.1371/journal.pone.0020014
50. Harris KM, Fasano A, Mann DL. Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J Immunol (2008) 181:4457-60.
51. Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-KerkhoffA, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 360:2426-37. doi:10.1056/NEJMoa0807865
52. Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A (2009) 106:7119-24. doi:10.1073/pnas.0902745106
53. 17 derived) human Th1 cells. Eur J Immunol (2012) 42:3180-8. doi:10.1002/eji.201242648
54. 4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum (2011) 63:2504-15. doi:10.1002/art.30332
55. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, et al. Late developmental plasticity in the T helper 17 lineage. Immunity (2009) 30:92-107. doi:10.1016/j.immuni.2008.11.005
56. 17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A (2010) 107:14751-6. doi:10.1073/pnas.1003852107
57. 17 phenotype. Eur J Immunol (2010) 40:3336-46. doi:10.1002/eji.201040755
58. 17 cells and the development of autoimmune diseases. Self Nonself (2011) 2:35-42. doi:10.4161/self.2.1.15639
59. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol (2007) 8:950-7. doi:10.1038/ni1497